Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CNS Pharmaceuticals, Inc. (CNSP)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | | | | 100.0% |
| Cost of goods sold | 0.5% | | | | 6163.1% |
| Gross profit | 99.5% | | | | -6063.1% |
| Research and development | 60.2% | | | | -74.3% |
| General and administrative | 38.6% | | | | -3007.2% |
| Depreciation | 0.1% | | | | |
| EBIT | -98.2% | | | | 3081.6% |
| Pre-tax income | -98.9% | | | | 25832.3% |
| Income taxes | 0.0% | | | | 0.0% |
| Net income | -98.9% | | | | 25832.3% |
|